Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
China NT Pharma Group Co., Ltd. ( (HK:1011) ) has issued an announcement.
China NT Pharma Group Co., Ltd. has issued a profit warning for the ten months ending October 31, 2024, expecting a reduced net loss of RMB35.0 million to RMB37.0 million, compared to a net loss of RMB152.9 million during the same period in 2023. This improvement is mainly due to the absence of losses from its previously disposed manufacturing business and the non-incurrence of a significant consultancy fee that was present in the prior period, suggesting a more streamlined operation moving forward.
More about China NT Pharma Group Co., Ltd.
China NT Pharma Group Co., Ltd. operates within the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company has been involved in manufacturing proprietary pharmaceutical products but has recently disposed of this business segment.
YTD Price Performance: -10.37%
Average Trading Volume: 789,385
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: HK$65.79M
For a thorough assessment of 1011 stock, go to TipRanks’ Stock Analysis page.